Marc Dechamps

Marc Dechamps

Marc Dechamps

Academic Director - Advanced Master in Biotech & MedTech Ventures - Solvay Brussels School of Economics and Management

Marc Dechamps is a biologist with extensive experience of more than 35 years in the pharmaceutical industry, with expertise in market development for new products including infectious diseases, immunological disorders, oncology, CNS disorders and vaccines at corporate pharma companies including GSK & ViiVHealthcare. Since 2016, Marc is founder and Managing Director of XMF consulting, a company which supports Biotech & BioPharma companies with strategic advice and management leadership in the field of Biologics – ATMP, ...

Marc served as Managing Director of Delphi Genetics (CDMO), interim CEO of eTheRNA Immunotherapies (Belgian mRNA clinical stage biotech company).

Currently Marc is co-Academic Director at the Solvay Brussels School of Economics & Management for the newly created Advanced Master in Biotech & MedTech Ventures, is responsible for the international representation of BioWin - the Life Sciences Cluster of Wallonia, provides strategic & business advice for Mithra Pharmaceuticals (CDMO), BioGenCell Europe and Bioxodes. Marc serves as President of the board of CEBR, the Council of European BioRegions and of the “Investsud Tech” Investsud group Belgium. Marc is also expert for Research & Innovation and investors’ dossiers. 

Join us in person on 19 May

Flanders.bio Strategic Partners

Flanders.bio Supporting Partners